Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment

Filip Yves De Vos; Willem Joost Lesterhuis; Roger Johannes Brüggemann; Winette Tita Van Der Graaf

doi:10.1097/CAD.0b013e32834be51a

Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment

Filip Yves De Vos^*, Willem Joost Lesterhuis, Roger Johannes Brüggemann, Winette Tita Van Der Graaf

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Abstract

A patient with metastatic ovarian cancer was treated with liposomal doxorubicin and carboplatin. She had an extravasation during liposomal doxorubicin infusion. Initially, she was treated conservatively with cold compresses and topical treatment. However, because of worsening of symptoms, she received dexrazoxane once daily for 3 days after which complete recovery occurred. This is the first casereport on symptomatic extravasation of liposomal doxorubicin treated with dexrazoxane.

Original language	English
Pages (from-to)	139-140
Number of pages	2
Journal	Anti-Cancer Drugs
Volume	23
Issue number	1
DOIs	https://doi.org/10.1097/CAD.0b013e32834be51a
Publication status	Published - 1 Jan 2012

Keywords

dexrazoxane
extravasation
liposomal doxorubicin

Access to Document

10.1097/CAD.0b013e32834be51a

Cite this

@article{5f145ac3065249cbb9cf87ee11ed5c66,

title = "Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment",

abstract = "A patient with metastatic ovarian cancer was treated with liposomal doxorubicin and carboplatin. She had an extravasation during liposomal doxorubicin infusion. Initially, she was treated conservatively with cold compresses and topical treatment. However, because of worsening of symptoms, she received dexrazoxane once daily for 3 days after which complete recovery occurred. This is the first casereport on symptomatic extravasation of liposomal doxorubicin treated with dexrazoxane.",

keywords = "dexrazoxane, extravasation, liposomal doxorubicin",

author = "\{De Vos\}, \{Filip Yves\} and Lesterhuis, \{Willem Joost\} and Br{\"u}ggemann, \{Roger Johannes\} and \{Van Der Graaf\}, \{Winette Tita\}",

year = "2012",

month = jan,

day = "1",

doi = "10.1097/CAD.0b013e32834be51a",

language = "English",

volume = "23",

pages = "139--140",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams \& Wilkins",

number = "1",

}

TY - JOUR

T1 - Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment

AU - De Vos, Filip Yves

AU - Lesterhuis, Willem Joost

AU - Brüggemann, Roger Johannes

AU - Van Der Graaf, Winette Tita

PY - 2012/1/1

Y1 - 2012/1/1

N2 - A patient with metastatic ovarian cancer was treated with liposomal doxorubicin and carboplatin. She had an extravasation during liposomal doxorubicin infusion. Initially, she was treated conservatively with cold compresses and topical treatment. However, because of worsening of symptoms, she received dexrazoxane once daily for 3 days after which complete recovery occurred. This is the first casereport on symptomatic extravasation of liposomal doxorubicin treated with dexrazoxane.

AB - A patient with metastatic ovarian cancer was treated with liposomal doxorubicin and carboplatin. She had an extravasation during liposomal doxorubicin infusion. Initially, she was treated conservatively with cold compresses and topical treatment. However, because of worsening of symptoms, she received dexrazoxane once daily for 3 days after which complete recovery occurred. This is the first casereport on symptomatic extravasation of liposomal doxorubicin treated with dexrazoxane.

KW - dexrazoxane

KW - extravasation

KW - liposomal doxorubicin

UR - https://www.scopus.com/pages/publications/82555166040

U2 - 10.1097/CAD.0b013e32834be51a

DO - 10.1097/CAD.0b013e32834be51a

M3 - Article

C2 - 21934601

AN - SCOPUS:82555166040

SN - 0959-4973

VL - 23

SP - 139

EP - 140

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

IS - 1

ER -

Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this